Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 30, 2024

Study Completion Date

September 30, 2024

Conditions
Obsessive-Compulsive Disorder (OCD)
Interventions
BEHAVIORAL

MCT

Metacognitive Therapy (MCT) is a 12-week manualized treatment for OCD targeting maladaptive thought patterns. Clinicians deliver structured sessions including: (1) Attention Training to modify focus, (2) Detached Mindfulness to change responses to intrusive thoughts, and (3) behavioral experiments to reduce compulsions. Treatment progresses through psychoeducation, challenging perfectionism, addressing thought control, and relapse prevention. Primary outcome: Y-BOCS; secondary: MCQ-30 and TFI. Based on the evidence-based myMCT protocol.

Trial Locations (2)

44320

IOMH Institute of Mental Health, Islamabad

Subhan Medical Centre Trust, Islamabad

All Listed Sponsors
lead

Northeast Normal University

OTHER

NCT07052812 - Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy | Biotech Hunter | Biotech Hunter